Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Matthew J. Brady to Receptor, Insulin

This is a "connection" page, showing publications Matthew J. Brady has written about Receptor, Insulin.

 
Connection Strength
 
 
 
0.491
 
  1. Ou H, Yan L, Mustafi D, Makinen MW, Brady MJ. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor. J Biol Inorg Chem. 2005 Dec; 10(8):874-86.
    View in: PubMed
    Score: 0.303
  2. Sargis RM, Neel BA, Brock CO, Lin Y, Hickey AT, Carlton DA, Brady MJ. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60.
    View in: PubMed
    Score: 0.118
  3. Brady MJ. IRS2 takes center stage in the development of type 2 diabetes. J Clin Invest. 2004 Oct; 114(7):886-8.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.